Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01105572 · ClinicalTrials.gov registry record · NA
Aetna_Intel Medicare Home Biomonitoring Study
A NA study of Congestive Heart Failure, sponsored by Aetna.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
- 1
- Study location
NCT01105572: Completed NA study of Congestive Heart Failure, sponsored by Aetna.
NCT01105572 is a NA study of Congestive Heart Failure that has completed, run by Aetna. The registered enrollment target is 316 participants, roughly in line with the 324-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01105572, a NA study of Congestive Heart Failure, has completed, sponsored by Aetna.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis is that use of Internet-connected home biomonitoring of weight, blood pressure and other indicators, in conjunction with nurse case management, will result in improved outcome for Medicare beneficiaries with with Congestive Heart Failure; compared to case management assistance without the biomonitoring device.
Primary Outcome
During the 6 month intervention period, it is expected that the time from entering the study until the first primary event (acute hospital admission, emergency room visit or death) will be, on average, longer for those using the Intel® Health Guide with case management (HG-CM) than for those in the routine case management (Case Management-Only Group). The primary measure to be compared across the study groups will be the unadjusted hazard ratio.
Conditions Studied
Interventions
- OTHER Case Management
- DEVICE Intel Health Guide
Study Locations (1)
New Jersey
- Aetna - Princeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT01105572 record still lists
NCT01105572 is an interventional study that assigns participants to a tested intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 324-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target.
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Case Management is the first listed.
NCT01105572 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01105572 about?
NCT01105572 is a clinical study titled "Aetna_Intel Medicare Home Biomonitoring Study". The hypothesis is that use of Internet-connected home biomonitoring of weight, blood pressure and other indicators, in conjunction with nurse case management, will result in improved outcome for Medicare beneficiaries with with Congestive Heart Failure; compared to case management assistance without...
What is the current status of trial NCT01105572?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2008-11. Estimated completion is 2010-04.
What conditions does trial NCT01105572 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT01105572?
The interventions under investigation include: Case Management (OTHER), Intel Health Guide (DEVICE).
Who is sponsoring clinical trial NCT01105572?
This trial is sponsored by Aetna, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01105572 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01105572's enrollment target sits among peer trials
316 13th of 51 higher than 39 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia